| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 1.40e-16 | 431 | 67 | 19 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8A1 MST1R OR2B11 OR7D4 ERBB2 ERBB4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 PALLD OR2W6P | 4.12e-12 | 1353 | 67 | 24 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 5.46e-12 | 884 | 67 | 20 | GO:0004930 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 5.96e-17 | 432 | 66 | 19 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 2.31e-16 | 465 | 66 | 19 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 5.00e-16 | 485 | 66 | 19 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 2.05e-15 | 524 | 66 | 19 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 4.46e-15 | 547 | 66 | 19 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 1.37e-14 | 582 | 66 | 19 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 6.37e-13 | 722 | 66 | 19 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 5.73e-10 | 1072 | 66 | 19 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR11H7 OR7D2 OR10Q1 RAPGEF4 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 1.10e-09 | 1395 | 66 | 21 | GO:0007186 |
| GeneOntologyBiologicalProcess | ERBB2-ERBB4 signaling pathway | 1.00e-04 | 5 | 66 | 2 | GO:0038135 | |
| GeneOntologyBiologicalProcess | regulation of cilium movement | 5.19e-04 | 49 | 66 | 3 | GO:0003352 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 5.19e-04 | 49 | 66 | 3 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 5.19e-04 | 49 | 66 | 3 | GO:0099633 | |
| GeneOntologyBiologicalProcess | ERBB4 signaling pathway | 5.44e-04 | 11 | 66 | 2 | GO:0038130 | |
| MousePheno | abnormal sensory neuron innervation pattern | 7.87e-05 | 92 | 35 | 4 | MP:0000968 | |
| MousePheno | abnormal motor neuron innervation pattern | 1.05e-04 | 37 | 35 | 3 | MP:0000940 | |
| MousePheno | abnormal innervation | 1.10e-04 | 193 | 35 | 5 | MP:0002184 | |
| MousePheno | abnormal nervous system development | OR8A1 DNAI1 STK36 ERBB2 ERBB4 OR10A4 CFAP206 BTAF1 CHN1 PALLD ITGB8 | 1.63e-04 | 1257 | 35 | 11 | MP:0003861 |
| MousePheno | abdominal situs inversus | 2.17e-04 | 9 | 35 | 2 | MP:0011249 | |
| Domain | Olfact_rcpt | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 1.23e-14 | 393 | 64 | 17 | IPR000725 |
| Domain | 7tm_1 | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 7.06e-12 | 677 | 64 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 8.58e-12 | 685 | 64 | 18 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 9.92e-12 | 691 | 64 | 18 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 1.02e-11 | 692 | 64 | 18 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 GPR33 OR7D2 OR10Q1 OR2C3 OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 6.19e-10 | 670 | 64 | 16 | IPR017452 |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 6.90e-05 | 4 | 64 | 2 | IPR016245 | |
| Domain | GF_recep_IV | 1.72e-04 | 6 | 64 | 2 | PF14843 | |
| Domain | GF_recep_IV | 1.72e-04 | 6 | 64 | 2 | IPR032778 | |
| Domain | Furin-like | 2.40e-04 | 7 | 64 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 2.40e-04 | 7 | 64 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 2.40e-04 | 7 | 64 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 2.40e-04 | 7 | 64 | 2 | PF01030 | |
| Domain | - | 2.40e-04 | 7 | 64 | 2 | 3.80.20.20 | |
| Domain | Furin_repeat | 1.71e-03 | 18 | 64 | 2 | IPR006212 | |
| Domain | FU | 1.71e-03 | 18 | 64 | 2 | SM00261 | |
| Domain | TyrKc | 3.42e-03 | 88 | 64 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.42e-03 | 88 | 64 | 3 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.50e-03 | 97 | 64 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.50e-03 | 97 | 64 | 3 | IPR008266 | |
| Domain | Glyco_hydro_catalytic_dom | 7.51e-03 | 38 | 64 | 2 | IPR013781 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 6.25e-14 | 417 | 52 | 17 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR7D2 OR10Q1 OR2C3 OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 5.54e-12 | 389 | 52 | 15 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 | 5.39e-11 | 636 | 52 | 17 | M41834 |
| Pathway | WP_GPCRS_ODORANT | 1.63e-06 | 157 | 52 | 7 | MM15872 | |
| Pathway | WP_GPCRS_OTHER | 2.66e-05 | 96 | 52 | 5 | MM15939 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.99e-05 | 186 | 52 | 6 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.72e-04 | 260 | 52 | 6 | M39397 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 7.19e-04 | 11 | 52 | 2 | MM15478 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 7.19e-04 | 11 | 52 | 2 | MM14760 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 1.01e-03 | 13 | 52 | 2 | M27729 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.01e-03 | 13 | 52 | 2 | MM15320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.08e-03 | 55 | 52 | 3 | M47952 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.18e-03 | 14 | 52 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 1.18e-03 | 14 | 52 | 2 | MM14531 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 1.36e-03 | 15 | 52 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 1.36e-03 | 15 | 52 | 2 | M27608 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.55e-03 | 16 | 52 | 2 | M562 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 1.55e-03 | 16 | 52 | 2 | M570 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 2.18e-03 | 70 | 52 | 3 | MM14984 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR10Q1 OR1F12P OR1F2P OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 3.50e-18 | 340 | 67 | 16 | 11875048 |
| Pubmed | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR10Q1 OR1F12P OR1F2P OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 3.50e-18 | 340 | 67 | 16 | 11802173 | |
| Pubmed | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR10Q1 OR1F12P OR1F2P OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 4.02e-18 | 343 | 67 | 16 | 32295537 | |
| Pubmed | OR8A1 OR2B11 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR10Q1 OR1F12P OR1F2P OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 4.62e-18 | 346 | 67 | 16 | 14611657 | |
| Pubmed | OR8A1 OR7D4 OR7A5 OR1B1 OR10A4 OR7C1 OR11H7 OR7D2 OR10Q1 OR2C3 OR1F12P OR1F2P OR1C1 OR4B1 OR7A17 OR2T4 OR7A10 OR2W6P | 9.95e-18 | 541 | 67 | 18 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR8A1 OR7D4 OR7A5 OR10A4 OR7C1 OR11H7 OR7D2 OR2C3 OR1F2P OR1C1 OR4B1 OR7A17 OR7A10 | 3.21e-16 | 219 | 67 | 13 | 12213199 |
| Pubmed | Specific repertoire of olfactory receptor genes in the male germ cells of several mammalian species. | 5.32e-12 | 24 | 67 | 6 | 9119360 | |
| Pubmed | Chromosomal location-dependent nonstochastic onset of odor receptor expression. | 1.38e-10 | 17 | 67 | 5 | 20668191 | |
| Pubmed | 1.88e-10 | 6 | 67 | 4 | 8929536 | ||
| Pubmed | 7.46e-10 | 23 | 67 | 5 | 10706615 | ||
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 8.87e-09 | 13 | 67 | 4 | 11014824 | |
| Pubmed | Expression of members of the putative olfactory receptor gene family in mammalian germ cells. | 1.54e-07 | 25 | 67 | 4 | 1370859 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 3.31e-07 | 74 | 67 | 5 | 15081110 | |
| Pubmed | 4.93e-07 | 33 | 67 | 4 | 17350283 | ||
| Pubmed | 2.45e-06 | 14 | 67 | 3 | 7528109 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 30201685 | ||
| Pubmed | The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. | 3.66e-06 | 2 | 67 | 2 | 10500112 | |
| Pubmed | Characterization of a tryptase mRNA expressed in the human basophil cell line KU812. | 3.66e-06 | 2 | 67 | 2 | 8434231 | |
| Pubmed | Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. | 3.66e-06 | 2 | 67 | 2 | 20022944 | |
| Pubmed | Cloning and characterization of a second complementary DNA for human tryptase. | 3.66e-06 | 2 | 67 | 2 | 2203827 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15685397 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 10898108 | ||
| Pubmed | Characterization of EGFR family gene aberrations in cholangiocarcinoma. | 3.66e-06 | 2 | 67 | 2 | 24927194 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 19244516 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 22699492 | ||
| Pubmed | Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. | 3.66e-06 | 2 | 67 | 2 | 9521329 | |
| Pubmed | The carbohydrate CT1 is expressed in topographically fixed glomeruli in the mouse olfactory bulb. | 3.66e-06 | 2 | 67 | 2 | 21699983 | |
| Pubmed | Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. | 3.66e-06 | 2 | 67 | 2 | 2187193 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 15567416 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 10391906 | ||
| Pubmed | The human mast cell tryptase tetramer: a fascinating riddle solved by structure. | 3.66e-06 | 2 | 67 | 2 | 10708850 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 33178818 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 17449330 | ||
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 31337736 | ||
| Pubmed | The chromosomal distribution of mouse odorant receptor genes. | 3.70e-06 | 54 | 67 | 4 | 8570653 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 28653892 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 31875544 | ||
| Pubmed | Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin. | 1.10e-05 | 3 | 67 | 2 | 22184199 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 12532415 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 20691762 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 9851845 | ||
| Pubmed | Involvement of the neuregulins and their receptors in cardiac and neural development. | 1.10e-05 | 3 | 67 | 2 | 8967893 | |
| Pubmed | ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. | 1.10e-05 | 3 | 67 | 2 | 23333248 | |
| Pubmed | Expression and potential role of ErbB receptors in type II endometrial cancer. | 1.10e-05 | 3 | 67 | 2 | 23395558 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 28065942 | ||
| Pubmed | Synapses form in skeletal muscles lacking neuregulin receptors. | 1.10e-05 | 3 | 67 | 2 | 15976301 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 24862237 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 15026342 | ||
| Pubmed | Olfactory marker protein (OMP) regulates formation and refinement of the olfactory glomerular map. | 1.10e-05 | 3 | 67 | 2 | 30498219 | |
| Pubmed | Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. | 1.10e-05 | 3 | 67 | 2 | 9920877 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10918572 | ||
| Pubmed | Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. | 1.10e-05 | 3 | 67 | 2 | 10839362 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 10798394 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19370475 | ||
| Pubmed | Expression and significance of HER family receptors in neuroblastic tumors. | 1.10e-05 | 3 | 67 | 2 | 21203803 | |
| Pubmed | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | 1.10e-05 | 3 | 67 | 2 | 25731189 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 23100016 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 25468910 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19748655 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 30128676 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 25568110 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 18022950 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 1.93e-05 | 27 | 67 | 3 | 32061665 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 23884929 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 16685269 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 2.19e-05 | 4 | 67 | 2 | 24557338 | |
| Pubmed | Absence of adenylyl cyclase 3 perturbs peripheral olfactory projections in mice. | 2.19e-05 | 4 | 67 | 2 | 17581954 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 19447869 | ||
| Pubmed | Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. | 2.19e-05 | 4 | 67 | 2 | 22910355 | |
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 2.19e-05 | 4 | 67 | 2 | 23991224 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 18985033 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 11425901 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 26648299 | ||
| Pubmed | Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. | 2.19e-05 | 4 | 67 | 2 | 12621152 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 9556621 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 9268701 | ||
| Pubmed | Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers. | 2.19e-05 | 4 | 67 | 2 | 19148499 | |
| Pubmed | Odor-evoked gene regulation and visualization in olfactory receptor neurons. | 2.19e-05 | 4 | 67 | 2 | 20080187 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 22327010 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 22854050 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 17177598 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 36411648 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 9771475 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 2.19e-05 | 4 | 67 | 2 | 20204273 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 21203579 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 34158475 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 15733067 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 12807903 | ||
| Pubmed | ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site. | 2.19e-05 | 4 | 67 | 2 | 19263517 | |
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 2.19e-05 | 4 | 67 | 2 | 18492703 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 27069134 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 17709650 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 8816440 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 15345710 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 17631500 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 26021752 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 9019162 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 15254894 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 23723069 | ||
| Pubmed | Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. | 3.64e-05 | 5 | 67 | 2 | 19632177 | |
| Cytoband | 1q44 | 2.13e-05 | 110 | 67 | 4 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 3.86e-05 | 128 | 67 | 4 | chr1q44 | |
| Cytoband | 7p21.1 | 4.76e-04 | 22 | 67 | 2 | 7p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.09e-03 | 797 | 67 | 6 | chr19p13 | |
| Cytoband | 19p13.1 | 2.27e-03 | 48 | 67 | 2 | 19p13.1 | |
| Cytoband | 19p13.12 | 2.46e-03 | 50 | 67 | 2 | 19p13.12 | |
| GeneFamily | Olfactory receptors, family 7 | 3.03e-07 | 113 | 44 | 6 | 154 | |
| GeneFamily | Olfactory receptors, family 1 | 2.62e-06 | 40 | 44 | 4 | 147 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 3.46e-05 | 4 | 44 | 2 | 1096 | |
| GeneFamily | Olfactory receptors, family 2 | 1.62e-04 | 113 | 44 | 4 | 149 | |
| GeneFamily | Dyneins, axonemal | 7.69e-04 | 17 | 44 | 2 | 536 | |
| GeneFamily | Olfactory receptors, family 10 | 1.12e-02 | 66 | 44 | 2 | 157 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.92e-07 | 195 | 67 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.92e-07 | 195 | 67 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.06e-07 | 196 | 67 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.06e-07 | 196 | 67 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.80e-06 | 170 | 67 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.66e-06 | 180 | 67 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 8.75e-06 | 185 | 67 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.95e-06 | 190 | 67 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.05e-05 | 192 | 67 | 5 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.05e-05 | 192 | 67 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 193 | 67 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.07e-05 | 193 | 67 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-05 | 193 | 67 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 194 | 67 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.13e-05 | 195 | 67 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.13e-05 | 195 | 67 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.16e-05 | 196 | 67 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 198 | 67 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 199 | 67 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.27e-05 | 200 | 67 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-05 | 200 | 67 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.25e-05 | 142 | 67 | 4 | 1eecbec805a873fa3539df0574670cf73c18c7b1 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 9.68e-05 | 159 | 67 | 4 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.02e-04 | 161 | 67 | 4 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 163 | 67 | 4 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_precursor|Distal / Age, Tissue, Lineage and Cell class | 1.17e-04 | 167 | 67 | 4 | 442ea71a581ed5a547a214132b9f1b0243fd0895 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 167 | 67 | 4 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-04 | 170 | 67 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.28e-04 | 171 | 67 | 4 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 171 | 67 | 4 | 2c7d73f1386ddd172839734c68ed3859a90f80f8 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.28e-04 | 171 | 67 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 1.31e-04 | 172 | 67 | 4 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 1.31e-04 | 172 | 67 | 4 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-04 | 172 | 67 | 4 | 3a76cfb2832790144a6da6406469ead0767916b5 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 1.31e-04 | 172 | 67 | 4 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-04 | 176 | 67 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 67 | 4 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 177 | 67 | 4 | 86c41d262142eeaa95ea7fa6668169eb1bb2953f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 67 | 4 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 178 | 67 | 4 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 178 | 67 | 4 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.49e-04 | 178 | 67 | 4 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.49e-04 | 178 | 67 | 4 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 178 | 67 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 179 | 67 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 179 | 67 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.53e-04 | 179 | 67 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.53e-04 | 179 | 67 | 4 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 180 | 67 | 4 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.56e-04 | 180 | 67 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.63e-04 | 182 | 67 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 183 | 67 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-04 | 183 | 67 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 183 | 67 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 184 | 67 | 4 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.70e-04 | 184 | 67 | 4 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 1.70e-04 | 184 | 67 | 4 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-04 | 184 | 67 | 4 | ce31684772e47a294155f368e50b49753f7c8e87 | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-04 | 184 | 67 | 4 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.73e-04 | 185 | 67 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-04 | 185 | 67 | 4 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 185 | 67 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.73e-04 | 185 | 67 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 1.73e-04 | 185 | 67 | 4 | f78be85dd6e443abb7af20f98ff351c1131ece4d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 186 | 67 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.81e-04 | 187 | 67 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 187 | 67 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.84e-04 | 188 | 67 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.84e-04 | 188 | 67 | 4 | 986aaf31161ec3d1e6c76ee2dd17f44848a21f7e | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.84e-04 | 188 | 67 | 4 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.88e-04 | 189 | 67 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.88e-04 | 189 | 67 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 189 | 67 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 189 | 67 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-04 | 189 | 67 | 4 | 033a2be8bbb7bfb437e6f1657b6ca02070c74aa8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 190 | 67 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 190 | 67 | 4 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 191 | 67 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 191 | 67 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 191 | 67 | 4 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 192 | 67 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 2.00e-04 | 192 | 67 | 4 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-04 | 192 | 67 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 193 | 67 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.04e-04 | 193 | 67 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.04e-04 | 193 | 67 | 4 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | 043dd0fc2f93e0bd1ca34ac3e196622b3e91df0f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 193 | 67 | 4 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-04 | 194 | 67 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.08e-04 | 194 | 67 | 4 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.12e-04 | 195 | 67 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-04 | 195 | 67 | 4 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-04 | 195 | 67 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-04 | 195 | 67 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| Computational | Genes in the cancer module 85. | 5.92e-04 | 51 | 35 | 3 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 8.20e-04 | 57 | 35 | 3 | MODULE_199 | |
| Computational | Genes in the cancer module 27. | 8.97e-04 | 355 | 35 | 6 | MODULE_27 | |
| Computational | Immune (defense) response. | 1.11e-03 | 142 | 35 | 4 | MODULE_223 | |
| Disease | Kartagener syndrome (is_implicated_in) | 2.04e-05 | 4 | 55 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Primary Ciliary Dyskinesia | 9.38e-05 | 47 | 55 | 3 | C4551720 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 9.48e-05 | 8 | 55 | 2 | DOID:5520 (is_marker_for) | |
| Disease | tryptase beta-2 measurement | 1.22e-04 | 9 | 55 | 2 | EFO_0008306 | |
| Disease | gallbladder neoplasm | 1.86e-04 | 11 | 55 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 1.86e-04 | 11 | 55 | 2 | C0153452 | |
| Disease | basophil measurement | 1.94e-04 | 60 | 55 | 3 | EFO_0803539 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.06e-04 | 14 | 55 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 3.06e-04 | 14 | 55 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 5.72e-04 | 19 | 55 | 2 | DOID:2876 (is_marker_for) | |
| Disease | urticaria | 6.34e-04 | 20 | 55 | 2 | EFO_0005531 | |
| Disease | Bronchiectasis | 7.69e-04 | 22 | 55 | 2 | C0006267 | |
| Disease | Nasopharyngeal carcinoma | 7.69e-04 | 22 | 55 | 2 | C2931822 | |
| Disease | stomach carcinoma (is_marker_for) | 9.17e-04 | 24 | 55 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Mental deterioration | 1.34e-03 | 29 | 55 | 2 | HP_0001268 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.63e-03 | 32 | 55 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | Kartagener Syndrome | 1.95e-03 | 35 | 55 | 2 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.95e-03 | 35 | 55 | 2 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.95e-03 | 35 | 55 | 2 | C4551906 | |
| Disease | Primary ciliary dyskinesia | 2.06e-03 | 36 | 55 | 2 | cv:C0008780 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.18e-03 | 37 | 55 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 2.42e-03 | 39 | 55 | 2 | DOID:0060074 (is_marker_for) | |
| Disease | kynurenine measurement | 2.42e-03 | 39 | 55 | 2 | EFO_0008529 | |
| Disease | Moyamoya disease | 2.54e-03 | 40 | 55 | 2 | MONDO_0016820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THLDMLRHLYQGCQV | 41 | P04626 | |
| TQLMPHGCLLEYVHE | 796 | Q15303 | |
| PLQYASHMEPQVCLH | 56 | Q96NT0 | |
| AMHLCRHLQLQYPEL | 136 | Q96HD9 | |
| PLMVIHHLEDCQYSQ | 61 | Q8TD06 | |
| VCWMPYHIHQGLLLT | 256 | Q49SQ1 | |
| SHMLLQQPLIYCHFA | 2776 | Q96DT5 | |
| LTAIPCANHKMHLYL | 1391 | Q13085 | |
| VMCLDIHVDHPYLVA | 386 | Q9UI46 | |
| QRLLKYTPQHMHCGA | 966 | Q14692 | |
| AHELYFPERVMQCHL | 356 | Q8IYR0 | |
| ICHPLHYMVIMNPHL | 126 | Q15622 | |
| HYMVIMNPHLCGLLV | 131 | Q15622 | |
| YTCHVQHEGLPEPLM | 281 | P17693 | |
| VAICDPLHYALVMNH | 126 | Q8NGR6 | |
| PLHYALVMNHQRCAC | 131 | Q8NGR6 | |
| LLAIGSDHCLHTPMY | 46 | Q8NHA8 | |
| QCMIPEHYNSHRGLI | 141 | P19256 | |
| DVPCHLQGRLMHLYA | 431 | Q9UBI9 | |
| CLHHNCEPEYIQLLI | 221 | Q8WXK4 | |
| VAICHPLRYPVLMNH | 156 | Q8NH00 | |
| LHYTIIMHPRLCGQL | 136 | Q8NHA6 | |
| LICCLLHQMYIADPN | 996 | Q9H0H0 | |
| AMIIESLGLCYHLHC | 1626 | Q8WWI1 | |
| LHYTVIMHPQLCLGL | 131 | Q8N628 | |
| DKLVVHLYHLCQMFP | 496 | P78316 | |
| QPCSMRHLVSHYLDI | 291 | Q9UHB4 | |
| CRPLHYTAKMIHQLC | 126 | Q96R84 | |
| AICDPLHYPVIMGHI | 126 | Q9H209 | |
| LHYPVIMGHISCAQL | 131 | Q9H209 | |
| CKPLHYAVLMHRALC | 131 | Q5JQS5 | |
| VSMHQDNHGYICLLI | 1281 | Q8WX93 | |
| ICHPLHYTVIMNPCL | 126 | Q8NG98 | |
| LDCMPPHGYIHVLSL | 216 | P26012 | |
| VCHPLHYTVIMNPQL | 126 | O76099 | |
| LYHIMMCLGNLIPRH | 211 | Q92772 | |
| TYLMLANHLVHTLCP | 391 | Q04446 | |
| VVCNHEHYIPLNLPM | 1071 | Q9BZ29 | |
| HPLLVQHLPHLYMCL | 1101 | O14981 | |
| GYLCLPYMALQQHHL | 406 | Q8NBF6 | |
| PCDYHQEVSLRVHLM | 181 | Q8NC69 | |
| GPCMEYLLHHKILET | 76 | Q5W0V3 | |
| LPPAHCETLRYLMAH | 386 | P15882 | |
| HLHSLCLLMLYLATG | 6 | Q12864 | |
| VAICHPLLYNIIMSH | 141 | Q8NGG7 | |
| PLLYNIIMSHHTCLL | 146 | Q8NGG7 | |
| ICHPLHYTARMNLCL | 126 | Q15619 | |
| VCRPLHYTVVMHPCL | 126 | P59922 | |
| ICHPLHYPSIMTGQL | 126 | Q8NGC8 | |
| CHPLHYTLIMTRELC | 131 | Q8NGQ4 | |
| KPLHYMNIISRQLCH | 126 | Q8NGF8 | |
| MPNTQLCPALVAHYH | 541 | Q8WZA2 | |
| PIMENHICDAKYHLG | 181 | Q15661 | |
| PIMENHICDAKYHLG | 181 | P20231 | |
| LLEQSLPYLHGMHLC | 456 | Q8N3R3 | |
| EGCLYQLNHHMEVLR | 986 | Q8WXH0 | |
| ICHPLHYMVIMNPQL | 126 | O76100 | |
| MIHEDTRHLLCPYCL | 611 | Q7Z3K3 | |
| ICHPLHYTVIMNPRL | 126 | O14581 | |
| VCHPLHYMIIMNPHL | 126 | Q96RA2 | |
| HYMIIMNPHLCGLLV | 131 | Q96RA2 | |
| IEPGMPLNHIEYCNH | 71 | P60153 | |
| PLNHIEYCNHEIMGK | 76 | P60153 | |
| HLLQVCCYHLPLMQV | 1016 | Q9NRP7 | |
| DLMQQSSELYLHCHP | 256 | Q9UNK9 | |
| IQHLRMHTGEKPYQC | 176 | Q7Z3I7 | |
| RIMEYPNDCIHISLH | 186 | Q8N614 | |
| VIYLLNPCHLVTMMH | 116 | Q5U3C3 | |
| PHILPHQDVLIMCYE | 246 | Q6FHJ7 | |
| LHTHCSYQLMLPEAI | 361 | Q96FJ0 | |
| LYLDMNGIIHPCTHP | 51 | Q9H0D6 | |
| IHRSPLCEYMINFIH | 361 | Q15561 | |
| LPHVLLPYMCHGDLL | 1156 | Q04912 | |
| CLMQHQRIHSGEKPY | 176 | Q96CX3 |